By Rick Archer ( March 26, 2019, 5:27 PM EDT) -- The Second Circuit on Tuesday upheld the dismissal of more than a dozen claims in multidistrict litigation alleging that Pfizer Inc. and Bristol-Myers Squibb Co. didn't warn consumers of the risks associated with the blood thinner Eliquis, saying the claims are barred by federal regulations....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.